4.7 Article

Effects of Neurokinin B Administration on Reproductive Hormone Secretion in Healthy Men and Women

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 99, Issue 1, Pages E19-E27

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2012-2880

Keywords

-

Funding

  1. Medical Research Council Experimental Medicine project grant
  2. Integrative Mammalian Biology Capacity Building Award
  3. National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme
  4. NIHR Clinical Lectureship
  5. Academy of Medical Sciences/Wellcome Starter Grant for Clinical Lecturers
  6. A Society for Endocrinology Early Career Grant
  7. Wellcome Trust/GlaxoSmithKline Translational Medicine Training Fellowships
  8. Wellcome Trust Research Training Fellowships
  9. NIHR
  10. NATIONAL INSTITUTE ON AGING [R01AG031763] Funding Source: NIH RePORTER
  11. Academy of Medical Sciences (AMS) [AMS-SGCL5-Jayasena] Funding Source: researchfish
  12. Medical Research Council [G0000566, G1000455] Funding Source: researchfish
  13. National Institute for Health Research [ACF-2008-21-018, ACF-2010-21-015, CDF-2009-02-05, CL-2009-21-004, CL-2014-21-003] Funding Source: researchfish
  14. MRC [G0000566, G1000455] Funding Source: UKRI

Ask authors/readers for more resources

Background: Neurokinin B (NKB) is a member of the tachykinin family of peptides. Inactivating mutations in the tachykinin 3 or tachykinin 3 receptor gene are associated with pubertal failure and congenital hypogonadotrophic hypogonadism in humans. This suggests that NKB may have a critical role in human reproduction. The effects of NKB administration have not been investigated previously in humans. Aim: The aim of this study was to determine the effects of iv administration of NKB on gonadotrophin secretion in healthy male and female volunteers. Methods: A total of 23 healthy men and 11 healthy women participated in the study. After an initial dose-finding study (study 1), menreceived a 4-hour infusion of vehicle (gelofusin) followed by a 4-hour infusion of NKB (2.56 or 5.12 nmol/kg/h) (study 2), and an 8-hour infusion of vehicle or NKB during different visits (study 3). Healthy women underwent a dose-finding study consisting of a 3-hour NKB administration during the follicular phase of the menstrual cycle, and the maximum dose of NKB was also tested during the preovulatory and midluteal phases of menstrual cycle (study 4). Results: Mean LH, FSH, and T secretion were not significantly altered during a 90-minute infusion of NKB (0.4-5.12 nmol/kg/h), or a 4-hour infusion of NKB (5.12 nmol/kg/h). No alterations in gonadotrophin secretion or LH pulsatility were observed during an 8-hour infusion of NKB when compared with vehicle. Doses of 0.64-5.12 nmol/kg/h NKB did not significantly alter LH, FSH, or estradiol secretion in healthy women during the follicular phase of the menstrual cycle. Finally, 5.12 nmol/kg/h did not significantly alter reproductive hormone secretion during the preovulatory or midluteal phases of the menstrual cycle. Conclusions: This is the first clinical study of NKB administration. None of the doses of NKB tested were associated with significant alterations in reproductive hormone secretion in healthy male or female volunteers. These novel data add to our understanding of the physiological actions of NKB in human reproduction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available